Kenneth J Cohen

7PUBLICATIONS
58CO-AUTHORS
Medical parasitologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 29, 2025
Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.

Paul Phan, Stacie L Stapleton, Gregory J Riggins

|Aug 29, 2023
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma.

Darren R Hargrave, Keita Terashima, Junichi Hara

|Jul 27, 2023
A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma.

Kenneth J Cohen, Vasu Munjapara, Dolly Aguilera

|Dec 22, 2022
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.

Craig Erker, Martin Mynarek, Simon Bailey

|Mar 10, 2021
An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity.

Harrison Naung, Kenneth J Cohen

|Dec 08, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.

Darren R Hargrave, Eric Bouffet, Uri Tabori

Pageof 2

Frequent Collaborators

3 joint publications

Darren R Hargrave

2 joint publications

Ira J Dunkel

2 joint publications

Lillian Tseng

2 joint publications

Jordan R Hansford